106 related articles for article (PubMed ID: 16320268)
21. Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now.
Goulden N; Virgo P; Grimwade D
Br J Haematol; 2006 Aug; 134(3):273-82. PubMed ID: 16848770
[TBL] [Abstract][Full Text] [Related]
22. Copy number alterations in childhood acute lymphoblastic leukemia and their association with minimal residual disease.
Steinemann D; Cario G; Stanulla M; Karawajew L; Tauscher M; Weigmann A; Göhring G; Ludwig WD; Harbott J; Radlwimmer B; Bartram C; Lichter P; Schrappe M; Schlegelberger B
Genes Chromosomes Cancer; 2008 Jun; 47(6):471-80. PubMed ID: 18311775
[TBL] [Abstract][Full Text] [Related]
23. An index approach for the Cox model with left censored covariates.
D'Angelo G; Weissfeld L;
Stat Med; 2008 Sep; 27(22):4502-14. PubMed ID: 18407573
[TBL] [Abstract][Full Text] [Related]
24. Cure rate model with interval censored data.
Kim YJ; Jhun M
Stat Med; 2008 Jan; 27(1):3-14. PubMed ID: 17516589
[TBL] [Abstract][Full Text] [Related]
25. Multiple augmentation for interval-censored data with measurement error.
Song X; Ma S
Stat Med; 2008 Jul; 27(16):3178-90. PubMed ID: 18040984
[TBL] [Abstract][Full Text] [Related]
26. [Prognostic factors for childhood acute non-mature B-lymphoblastic leukemia].
Jiang H; Gu LJ; Xue HL; Tang JY; Chen J; Pan C; Chen J; Xu C; Dong L; Zhou M
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):290-4. PubMed ID: 18554450
[TBL] [Abstract][Full Text] [Related]
27. [Minimal residual disease in childhood acute leukemias].
Pawińska K; Balwierz W; Baran J
Przegl Lek; 2006; 63(1):41-3. PubMed ID: 16892899
[TBL] [Abstract][Full Text] [Related]
28. Analysis of interval-censored data from circular migrant and non-migrant sexual partnerships using the EM algorithm.
Zuma K; Lurie M; Jorgensen M
Stat Med; 2007 Jan; 26(2):309-19. PubMed ID: 16538697
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia.
Agrawal S; Unterberg M; Koschmieder S; zur Stadt U; Brunnberg U; Verbeek W; Büchner T; Berdel WE; Serve H; Müller-Tidow C
Cancer Res; 2007 Feb; 67(3):1370-7. PubMed ID: 17283175
[TBL] [Abstract][Full Text] [Related]
30. [Using capture-recapture models to estimate transition rates between states in interval-censored data].
Viallefont A; Auget JL
Rev Epidemiol Sante Publique; 1999 Dec; 47(6):627-34. PubMed ID: 10673597
[TBL] [Abstract][Full Text] [Related]
31. Quantification of free total plasma DNA and minimal residual disease detection in the plasma of children with acute lymphoblastic leukemia.
Schwarz AK; Stanulla M; Cario G; Flohr T; Sutton R; Möricke A; Anker P; Stroun M; Welte K; Bartram CR; Schrappe M; Schrauder A
Ann Hematol; 2009 Sep; 88(9):897-905. PubMed ID: 19165483
[TBL] [Abstract][Full Text] [Related]
32. Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible.
Dworzak MN; Gaipa G; Ratei R; Veltroni M; Schumich A; Maglia O; Karawajew L; Benetello A; Pötschger U; Husak Z; Gadner H; Biondi A; Ludwig WD; Basso G
Cytometry B Clin Cytom; 2008 Nov; 74(6):331-40. PubMed ID: 18548617
[TBL] [Abstract][Full Text] [Related]
33. A pattern-mixture model for the analysis of censored quality-of-life data.
Li H; Heitjan DF
Stat Med; 2006 May; 25(9):1533-46. PubMed ID: 16435338
[TBL] [Abstract][Full Text] [Related]
34. Survival curve estimation for informatively coarsened discrete event-time data.
Shardell M; Scharfstein DO; Bozzette SA
Stat Med; 2007 May; 26(10):2184-202. PubMed ID: 16998829
[TBL] [Abstract][Full Text] [Related]
35. Modeling the association of bivariate interval-censored data using the copula approach.
Bogaerts K; Lesaffre E
Stat Med; 2008 Dec; 27(30):6379-92. PubMed ID: 18825653
[TBL] [Abstract][Full Text] [Related]
36. The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia.
Al-Mawali A; Gillis D; Lewis I
Am J Clin Pathol; 2009 Jan; 131(1):16-26. PubMed ID: 19095561
[TBL] [Abstract][Full Text] [Related]
37. [Prognostic value of minimal residual disease in childhood B-cell acute lymphoblastic leukemia].
Tie LJ; Gu LJ; Chen J; Jiang LM; Dong L; Pan C; Ye H; Song DL; Xue HL; Tang JY; Wang YP; Chen J
Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):120-3. PubMed ID: 16732969
[TBL] [Abstract][Full Text] [Related]
38. A semiparametric model for regression analysis of interval-censored failure time data.
Finkelstein DM; Wolfe RA
Biometrics; 1985 Dec; 41(4):933-45. PubMed ID: 3830259
[TBL] [Abstract][Full Text] [Related]
39. Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma.
Andersen NS; Pedersen LB; Laurell A; Elonen E; Kolstad A; Boesen AM; Pedersen LM; Lauritzsen GF; Ekanger R; Nilsson-Ehle H; Nordström M; Fredén S; Jerkeman M; Eriksson M; Väärt J; Malmer B; Geisler CH
J Clin Oncol; 2009 Sep; 27(26):4365-70. PubMed ID: 19652064
[TBL] [Abstract][Full Text] [Related]
40. Comparison of minimal residual disease (MRD) estimated by flow cytometry and by real-time quantitative PCR of Wilms tumor gene 1 (WT1) transcript expression in children with acute lymphoblastic leukemia.
Chen JS; Hsiao CC; Sheen JM; Cheng CN
Leuk Res; 2007 Oct; 31(10):1351-7. PubMed ID: 17445885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
